サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1401821

喘息治療薬市場：薬剤クラス別、製品タイプ別、投与経路別、国別、地域別：産業分析、市場規模、市場シェア、2023年～2030年予測

Asthma Therapeutics Market, By Drug Class, By Product Type, By Route of Administrations, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 301 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
喘息治療薬市場：薬剤クラス別、製品タイプ別、投与経路別、国別、地域別：産業分析、市場規模、市場シェア、2023年～2030年予測
出版日: 2024年01月01日
発行: AnalystView Market Insights
ページ情報: 英文 301 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

喘息治療薬市場規模は2022年に241億米ドルと評価され、2023年から2030年にかけてCAGR 5.1%で拡大する見込みです。

喘息治療薬市場- 市場力学

呼吸器疾患の急増と費用効率の高い治療オプションへの需要が市場需要を促進

喘息治療薬の重要性の背景には、呼吸器疾患の急増とコスト効率の高い治療オプションへの需要があります。世界保健機関（WHO）の2023年5月の報告書によると、2019年には約2億6,200万人が喘息に罹患し、世界で4億5,500万人が死亡しました。公害、アレルゲン、埃などの屋内外の誘因の増加、ライフスタイルの進化などの要因が、喘息治療薬セクターの成長を促進すると予想されます。さらに、患者、介護者、医療従事者の間で喘息に対する認識や教育が高まり、治療が強化される可能性が高いです。専門家の間で知識や進歩を広めるために毎年開催されるWorld Congress of Asthma（世界喘息会議）のようなイベントは、喘息という病気を理解し、治療法を進歩させるのに役立っています。生物製剤、バイオシミラー、吸入器、ネブライザー、スマートデバイスなど、喘息患者に対応する新規薬剤やデバイスの研究開発（R&D）への投資は、喘息管理を強化し、市場拡大を促進すると期待されています。特に、バイオサナファーマは、喘息と慢性特発性じんま疹の治療薬としてFDAに承認されているオマリズマブのバイオシミラーの第1相臨床試験を完了しました。このようなブレークスルーは、患者の治療選択肢へのアクセスを向上させる上で極めて重要です。

喘息治療薬市場-主な洞察

弊社のリサーチアナリストの分析によると、世界市場は予測期間（2023-2030年）に約5.1%のCAGRで毎年成長すると予測されています。

薬剤クラス別では、併用療法が2022年に最大の市場シェアを示すと予測されています。

製品タイプ別では、吸入療法が2022年の主要タイプです。

地域別では、北米が2022年に収益を生み出す主要市場です。

喘息治療薬市場-セグメンテーション分析：

喘息治療薬の世界市場は、薬剤クラス別、製品タイプ別、投与経路別、地域別に区分されます。

薬剤クラス別では、併用療法、抗炎症薬、気管支拡張薬の3つに分類されます。2022年には、吸入コルチコステロイドと長時間作用性β作動薬の組み合わせに代表される併用療法分野が、治療薬分類の中で主要な市場シェアを占めていました。このクラスは、治療効果の増幅、広範な入手可能性、患者の服薬アドヒアランスの向上で高く評価されています。

市場は、投与経路によって経口薬、吸入薬、その他の方法の3つに分類されます。2022年には、喘息治療戦略における肺ドラッグデリバリーシステムの高い採用率と患者のコンプライアンス向上により、吸入薬セグメントが最大の売上シェアを占めました。代替喘息治療に関する患者の意識の高まりと、これらの先進ドラッグデリバリーシステムに関連する簡便性が、予測期間にわたってこのセグメントの成長を促進しています。

喘息治療薬市場-地理的洞察

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。これらの地域は、ビジネスをもたらす国によってさらに分けられます。

喘息治療薬市場-競合情勢：

製薬・ヘルスケアセクターの喘息治療薬を専門とする企業は、多様な戦略を採用して自社の製品を強化しています。その焦点は、新薬、製剤、送達システムを革新して導入するための継続的な研究開発（R&D）に変わりはありません。これには、特定の炎症経路をターゲットにした新薬の創出や、より効果的な薬剤投与のための先進的な吸入技術の導入などが含まれます。企業は、喘息治療薬の有効性と安全性を示すために、臨床試験やエビデンスに基づく研究を実施することを優先しています。規制当局の承認を取得し、厳格な基準を遵守することは、市場への浸透と受容に不可欠です。さらに、個々の患者の特性、遺伝、治療に対する反応に基づいて治療をカスタマイズすることを意図した、個別化医療への取り組みが急増しています。これには、バイオマーカーや予測分析を掘り下げて、特定の薬物療法や治療でより恩恵を受ける可能性のある患者サブグループを特定することも含まれます。さらに、マーケティング戦略の中心は、喘息管理における最新の進歩についてヘルスケアプロバイダーや患者を教育し、治療計画を遵守することの重要性を強調し、利用可能な選択肢についての認識を高めることです。さらに、企業は共同研究やパートナーシップに積極的に取り組み、研究機関、支援団体、ヘルスケア組織と協力して技術革新を推進し、患者のケアを強化し、市場での存在感を高めています。業界の主要企業は、新製品の上市、承認取得、買収・合併など、自社の地位を強化するためにさまざまな事業戦略を実施しています。

目次

第1章 喘息治療薬市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 喘息治療薬の主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 喘息治療薬業界の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 喘息治療薬市場：COVID-19感染症の影響分析

  • 新型コロナウイルス感染症以前の影響分析
  • 新型コロナウイルス感染症後の影響分析

第6章 喘息治療薬市場情勢

  • 喘息治療薬市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 喘息治療薬市場- 薬剤クラス別

  • 概要
    • 薬剤クラス別のセグメントシェア分析
    • 抗炎症
    • 気管支拡張薬
    • 併用療法

第8章 喘息治療薬市場- 製品タイプ別

  • 概要
    • 製品タイプ別セグメントシェア分析
    • 吸入器
    • ネブライザー

第9章 喘息治療薬市場- 投与経路別

  • 概要
    • 投与経路別セグメントシェア分析
    • 経口
    • 吸入
    • その他

第10章 喘息治療薬市場- 地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東およびアフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- 喘息治療薬業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Teva Pharmaceutical Industries Ltd.
    • GSK plc.
    • Merck&Co., Inc.
    • F. Hoffmann-La Roche Ltd
    • AstraZeneca
    • Boehringer Ingelheim International GmbH.
    • Sanofi
    • Koninklijke Philips NV
    • BD
    • Sunovion Pharmaceuticals, Inc.
    • その他

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Asthma Therapeutics Market: Drug Class Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Drug Class
  • TABLE Global Asthma Therapeutics Market, by Drug Class 2018-2030 (USD Million)
  • TABLE Asthma Therapeutics Market: Product Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Asthma Therapeutics Market, by Product Type 2018-2030 (USD Million)
  • TABLE Asthma Therapeutics Market: Route of Administration Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Route of Administration
  • TABLE Global Asthma Therapeutics Market, by Route of Administration 2018-2030 (USD Million)
  • TABLE Asthma Therapeutics Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Asthma Therapeutics Market, by Region 2018-2030 (USD Million)
  • TABLE North America Asthma Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Asthma Therapeutics Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE North America Asthma Therapeutics Market, by Product Type, 2018-2030 (USD Million)
  • TABLE North America Asthma Therapeutics Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Europe Asthma Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Asthma Therapeutics Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Europe Asthma Therapeutics Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Europe Asthma Therapeutics Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Asia Pacific Asthma Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Asthma Therapeutics Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Asia Pacific Asthma Therapeutics Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Asthma Therapeutics Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Latin America Asthma Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Asthma Therapeutics Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Latin America Asthma Therapeutics Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Latin America Asthma Therapeutics Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Asthma Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Asthma Therapeutics Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Asthma Therapeutics Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Asthma Therapeutics Market, by Route of Administration, 2018-2030 (USD Million)

List of Figures

  • FIGURE Asthma Therapeutics Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Drug Class segment market share analysis, 2022 & 2030
  • FIGURE Drug Class segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Product Type segment market share analysis, 2022 & 2030
  • FIGURE Product Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Route of Administration segment market share analysis, 2022 & 2030
  • FIGURE Route of Administration segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Asthma Therapeutics Market share and leading players, 2022
  • FIGURE Europe Asthma Therapeutics Market share and leading players, 2022
  • FIGURE Asia Pacific Asthma Therapeutics Market share and leading players, 2022
  • FIGURE Latin America Asthma Therapeutics Market share and leading players, 2022
  • FIGURE Middle East and Africa Asthma Therapeutics Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Asthma Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Asthma Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Asthma Therapeutics Market share analysis by country, 2022
  • FIGURE Germany Asthma Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Asthma Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Asthma Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Asthma Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Asthma Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Asthma Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Asthma Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Asthma Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Asthma Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Asthma Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Asthma Therapeutics Market share analysis by country, 2022
  • FIGURE India Asthma Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Asthma Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Asthma Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Asthma Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Asthma Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Asthma Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Asthma Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Asthma Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Asthma Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Asthma Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Asthma Therapeutics Market share analysis by country, 2022
  • FIGURE Brazil Asthma Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Asthma Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Asthma Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Asthma Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Asthma Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Asthma Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Asthma Therapeutics Market share analysis by country, 2022
  • FIGURE Saudi Arabia Asthma Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Asthma Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Asthma Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Asthma Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Asthma Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Asthma Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Asthma Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV2007

REPORT HIGHLIGHT

Asthma Therapeutics Market size was valued at USD 24,100 Million in 2022, expanding at a CAGR of 5.1% from 2023 to 2030.

Asthma therapeutics encompass a spectrum of medicines and interventions devised to manage and relieve the symptoms of asthma, a persistent respiratory condition marked by airway inflammation and increased responsiveness. These therapies aim to regulate manifestations like wheezing, breath shortness, chest constriction, and coughing. They fall into two primary categories: long-term control drugs that aim to prevent symptoms and diminish airway inflammation, and quick-relief or rescue medications for immediate relief during asthma attacks. Long-term control medications commonly involve inhaled corticosteroids, long-acting beta-agonists, leukotriene modifiers, and biologics, while short-acting beta-agonists and anticholinergics are typically used as rescue drugs. Additionally, treatment plans may incorporate tailored approaches, lifestyle adjustments, and educational programs on managing asthma to enhance individuals' control and enhance their quality of life while reducing the risk of asthma flare-ups. Consistent monitoring and adjustment of treatment by healthcare professionals are crucial for effective asthma care.

Asthma Therapeutics Market- Market Dynamics

Surge in respiratory illnesses alongside the demand for cost-efficient treatment options to propel market demand

The surge in respiratory illnesses alongside the demand for cost-efficient treatment options underlies the significance of asthma therapeutics. According to the World Health Organization's (WHO) May 2023 report, approximately 262 million people were affected by asthma in 2019, resulting in 455,000 global deaths. Factors such as increasing indoor and outdoor triggers like pollution, allergens, dust, and evolving lifestyles are anticipated to drive growth in the asthma therapeutics sector. Furthermore, heightened awareness and education about asthma among patients, caregivers, and medical practitioners are likely to augment treatments. Events like the World Congress of Asthma, held annually to disseminate knowledge and advancements among experts, aid in comprehending the disease and advancing treatment options. Investments in research and development (R&D) for novel drugs and devices catering to asthma patients, such as biologics, biosimilars, inhalers, nebulizers, and smart devices, are expected to enhance asthma management and promote market expansion. Notably, BiosanaPharma completed phase 1 clinical trials for a biosimilar to omalizumab, an FDA-approved drug for asthma and chronic idiopathic urticaria. Such breakthroughs are pivotal in enhancing patient access to treatment options.

Asthma Therapeutics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.1% over the forecast period (2023-2030)

Based on Drug Class segmentation, combination therapy was predicted to show maximum market share in the year 2022

Based on Product Type segmentation, inhaled was the leading type in 2022

On the basis of region, North America was the leading revenue generator in 2022

Asthma Therapeutics Market- Segmentation Analysis:

The Global Asthma Therapeutics Market is segmented on the basis of Drug Class, Product Type, Route of Administrations, and Region.

The market is divided into three categories based on Drug Class: combination therapy, anti-inflammatory drugs, and bronchodilators. In 2022, the combination therapy segment, notably the combination of inhaled corticosteroids with long-acting beta-agonists, held the primary market share within the therapeutic class. This class is acclaimed for its amplified therapeutic effects, widespread availability, and improved patient adherence to medication.

The market is divided into three categories based on route of administration: oral, inhaled, and other methods. In 2022, the inhaled drugs segment claimed the largest revenue share due to the higher adoption rates and improved patient compliance with pulmonary drug delivery systems in asthma treatment strategies. The escalating awareness among patients regarding alternative asthma therapies and the simplicity associated with these advanced drug delivery systems are driving the growth of this segment over the projected period.

Asthma Therapeutics Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Asthma Therapeutics Market- Competitive Landscape:

Companies specializing in asthma therapeutics in the pharmaceutical and healthcare sectors employ diverse strategies to enhance their offerings. Their focus remains steadfast on continuous research and development (R&D) to innovate and introduce new medications, formulations, and delivery systems. This involves creating novel drugs targeting specific inflammatory pathways or introducing advanced inhaler technologies for more effective drug administration. Companies prioritize conducting clinical trials and evidence-based studies to showcase the efficacy and safety of their asthma medications. Obtaining regulatory approvals and complying with rigorous standards are critical for market penetration and acceptance. Moreover, there is a burgeoning emphasis on personalized medicine approaches, intending to customize treatments based on individual patient characteristics, genetics, and responses to therapies. This includes delving into biomarkers and predictive analytics to identify patient subgroups that may benefit more from specific medications or therapies. Furthermore, marketing strategies center on educating healthcare providers and patients about the latest advancements in asthma management, emphasizing the importance of adhering to treatment plans and increasing awareness about available options. Additionally, companies actively engage in collaborations and partnerships, collaborating with research institutions, advocacy groups, and healthcare organizations to drive innovation, enhance patient care, and broaden their market presence. Key industry players are implementing various business strategies to fortify their positions, including new product launches, obtaining approvals, and engaging in acquisitions and mergers.

Recent Developments:

In February 2022, Mankind Pharma revealed an agreement with Dr. Reddy's Laboratories Ltd. to obtain Combihale and Daffy. Combihale, an inhaler brand used for treating asthma and COPD, was valued at USD 109 million with a growth rate of 14%. This strategic move is anticipated to bolster the company's product portfolio and confer a competitive advantage against its rivals.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ASTHMA THERAPEUTICS MARKET KEY PLAYERS

  • Teva Pharmaceutical Industries Ltd.
  • GSK plc.
  • Merck& Co., Inc.
  • F. Hoffmann-La Roche Ltd
  • AstraZeneca
  • Boehringer Ingelheim International GmbH.
  • Sanofi
  • Koninklijke Philips N.V.
  • BD
  • Sunovion Pharmaceuticals, Inc.
  • Others

GLOBAL ASTHMA THERAPEUTICS MARKET, BY DRUG CLASS

  • Anti-inflammatory
  • Bronchodilators
  • Combination Therapy

GLOBAL ASTHMA THERAPEUTICS MARKET, BY PRODUCT TYPE

  • Inhaler
  • Nebulizers

GLOBAL ASTHMA THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATIONS

  • Oral
  • Inhaled
  • Others

GLOBAL ASTHMA THERAPEUTICS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Asthma Therapeutics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Asthma Therapeutics Market Snippet by Drug Class
    • 2.1.2. Asthma Therapeutics Market Snippet by Product Type
    • 2.1.3. Asthma Therapeutics Market Snippet by Route of Administration
    • 2.1.4. Asthma Therapeutics Market Snippet by Country
    • 2.1.5. Asthma Therapeutics Market Snippet by Region
  • 2.2. Competitive Insights

3. Asthma Therapeutics Key Market Trends

  • 3.1. Asthma Therapeutics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Asthma Therapeutics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Asthma Therapeutics Market Opportunities
  • 3.4. Asthma Therapeutics Market Future Trends

4. Asthma Therapeutics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Asthma Therapeutics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Asthma Therapeutics Market Landscape

  • 6.1. Asthma Therapeutics Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Asthma Therapeutics Market - By Drug Class

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Drug Class, 2022 & 2030 (%)
    • 7.1.2. Anti-inflammatory
    • 7.1.3. Bronchodilators
    • 7.1.4. Combination Therapy

8. Asthma Therapeutics Market - By Product Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
    • 8.1.2. Inhaler
    • 8.1.3. Nebulizers

9. Asthma Therapeutics Market - By Route of Administration

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Route of Administration, 2022 & 2030 (%)
    • 9.1.2. Oral
    • 9.1.3. Inhaled
    • 9.1.4. Others

10. Asthma Therapeutics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Asthma Therapeutics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Asthma Therapeutics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Asthma Therapeutics Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Asthma Therapeutics Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Asthma Therapeutics Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Asthma Therapeutics Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Teva Pharmaceutical Industries Ltd.
    • 11.2.2. GSK plc.
    • 11.2.3. Merck& Co., Inc.
    • 11.2.4. F. Hoffmann-La Roche Ltd
    • 11.2.5. AstraZeneca
    • 11.2.6. Boehringer Ingelheim International GmbH.
    • 11.2.7. Sanofi
    • 11.2.8. Koninklijke Philips N.V.
    • 11.2.9. BD
    • 11.2.10. Sunovion Pharmaceuticals, Inc.
    • 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us